Leading the in vivo gene editing revolution
Intellia is aiming to harness CRISPR gene editing and other core technologies to address a range of diseases and unmet needs for patients.
Read our news updates
Discover our programs and pipeline
We are focused on revolutionizing medicine by developing product candidates for a range of severe diseases leveraging CRISPR expertise and other core technologies and therapeutic approaches.
DiscoverHow can you contribute to our efforts to change life stories with genome editing?
At Intellia, we are aiming to revolutionize medicine by leveraging CRISPR gene editing and other core technologies to durably treat the root causes of disease.
Join UsIntellia proudly fosters a culture in which groundbreaking science and exceptional people thrive together